Literature DB >> 11757584

Phenotype variability in 130 adult patients with respiratory chain disorders.

J Finsterer1, C Jarius, H Eichberger.   

Abstract

Despite continuously improving diagnostic facilities, respiratory chain disorders (RCDs) are easily overlooked or misdiagnosed. We thus studied phenotype variability and the diagnostic potential of clinical and laboratory investigations in patients with RCD. We retrospectively evaluated clinical and laboratory investigations in 130 patients with RCD: 63 women and 67 men, aged 17-87 years, diagnosed between January 1992 and December 1999. mtDNA mutations were found in 20 patients; a respiratory chain defect but no mutation in 4; an abnormal lactate stress test but no mutation or biochemical defect in 66; and ragged-red fibres or reduced oxidative enzyme staining but no mutation, biochemical defect or abnormal lactate stress test in 40 patients. The most frequent initial manifestation of RCD were limb weakness, muscle pain and sensory disturbances. The most frequent clinical findings at diagnosis were muscle pain, fatiguability, limb weakness, reduced tendon reflexes and muscle wasting, irrespective of the diagnostic evidence. Mean age at onset, disease duration and time until diagnosis were 39, 14 and 13 years, respectively, without sex differences. The family history was positive in 29% of the patients. Hyperlipidaemia was found in 45%, hyper-CK-aemia in 42%, short stature in 33%, thyroid dysfunction in 17%, diabetes in 12%, and epilepsy in 8% of the patients. Laboratory investigations that prove useful to support the diagnosis of RCD are muscle biopsy, electromyography, lactate stress testing, echocardiography and mtDNA analysis. Systems most often involved in RCDs were the PNS, CNS, endocrine system and heart. The diagnosis of RCD requires awareness of the great phenotypic heterogeneity and an individualized, integral, multidisciplinary approach.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757584     DOI: 10.1023/a:1012415810881

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  30 in total

1.  Mitochondrial encephalomyopathies: gene mutation.

Authors: 
Journal:  Neuromuscul Disord       Date:  2001-01       Impact factor: 4.296

Review 2.  Mitochondrial respiratory chain disorders I: mitochondrial DNA defects.

Authors:  J V Leonard; A H Schapira
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

3.  Serial electroencephalographic findings in patients with MELAS.

Authors:  S Fujimoto; K Mizuno; H Shibata; M Kanayama; M Kobayashi; N Sugiyama; K Ban; T Ishikawa; T Itoh; H Togari; Y Wada
Journal:  Pediatr Neurol       Date:  1999-01       Impact factor: 3.372

4.  Clinical, morphological, biochemical, and neuroradiological features of mitochondrial encephalomyopathies. Presentation of 19 patients.

Authors:  A Lindner; E Hofmann; M Naumann; G Becker; H Reichmann
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

Review 5.  Mitochondrial disorders.

Authors:  C T Moraes
Journal:  Curr Opin Neurol       Date:  1996-10       Impact factor: 5.710

6.  Clinical features of MELAS and mitochondrial DNA mutations.

Authors:  Y Goto
Journal:  Muscle Nerve Suppl       Date:  1995

Review 7.  Neurological presentations of mitochondrial diseases.

Authors:  M Zeviani; B Bertagnolio; G Uziel
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 8.  ECG abnormalities in myopathies, coronary heart disease and controls.

Authors:  J Finsterer; C Stöllberger; K Köcher; B Mamoli
Journal:  Herz       Date:  1997-10       Impact factor: 1.443

9.  Progressive myoclonus epilepsies: an electroclinical, biochemical, morphological and molecular genetic study of 17 cases.

Authors:  S Franceschetti; C Antozzi; S Binelli; F Carrara; N Nardocci; M Zeviani; G Avanzini
Journal:  Acta Neurol Scand       Date:  1993-03       Impact factor: 3.209

10.  Functional involvement of central nervous system in mitochondrial disorders.

Authors:  V Di Lazzaro; D Restuccia; S Servidei; M Valeriani; R Nardone; G Manfredi; G Silvestri; E Ricci; P Tonali
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1997-06
View more
  11 in total

Review 1.  Neuromuscular and systemic presentations in adults: diagnoses beyond MERRF and MELAS.

Authors:  Bruce H Cohen
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

2.  Basal Ganglia calcification in mitochondrial disorders.

Authors:  Josef Finsterer; Wolfgang Kopsa
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

Review 3.  Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.

Authors:  F Sedel; I Gourfinkel-An; O Lyon-Caen; M Baulac; J-M Saudubray; V Navarro
Journal:  J Inherit Metab Dis       Date:  2007-10-22       Impact factor: 4.982

4.  Targeted exome sequencing of suspected mitochondrial disorders.

Authors:  Daniel S Lieber; Sarah E Calvo; Kristy Shanahan; Nancy G Slate; Shangtao Liu; Steven G Hershman; Nina B Gold; Brad A Chapman; David R Thorburn; Gerard T Berry; Jeremy D Schmahmann; Mark L Borowsky; David M Mueller; Katherine B Sims; Vamsi K Mootha
Journal:  Neurology       Date:  2013-04-17       Impact factor: 9.910

Review 5.  Adult-onset leukodystrophies from respiratory chain disorders: do they exist?

Authors:  Ettore Salsano; Laura Farina; Costanza Lamperti; Giuseppe Piscosquito; Franco Salerno; Lucia Morandi; Franco Carrara; Eleonora Lamantea; Massimo Zeviani; Graziella Uziel; Mario Savoiardo; Davide Pareyson
Journal:  J Neurol       Date:  2013-01-29       Impact factor: 4.849

6.  Reproducibility of the lactate stress test.

Authors:  Josef Finsterer
Journal:  Metab Brain Dis       Date:  2003-06       Impact factor: 3.584

7.  Increased prevalence of malignancy in adult mitochondrial disorders.

Authors:  J Finsterer; E Krexner
Journal:  J Med Life       Date:  2013-12-25

8.  Mitochondrial Myopathy in Follow-up of a Patient With Chronic Fatigue Syndrome.

Authors:  Fernando Galán; Isabel de Lavera; David Cotán; José A Sánchez-Alcázar
Journal:  J Investig Med High Impact Case Rep       Date:  2015-09-24

9.  Complex-I defect with minimal manifestations.

Authors:  Josef Finsterer; Madleine Melichart; Adelheid Wöhrer
Journal:  Arch Med Sci       Date:  2014-02-23       Impact factor: 3.318

10.  A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome

Authors:  Julie Thompson Legault; Laura Strittmatter; Jessica Tardif; Rohit Sharma; Vanessa Tremblay-Vaillancourt; Chantale Aubut; Gabrielle Boucher; Clary B Clish; Denis Cyr; Caroline Daneault; Paula J Waters; Luc Vachon; Charles Morin; Catherine Laprise; John D Rioux; Vamsi K Mootha; Christine Des Rosiers
Journal:  Cell Rep       Date:  2015-10-22       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.